Completed Mesothelioma Clinical Trials
Clinical trials may help researchers better understand mesothelioma development and treatment. Clinical studies are considered completed once all treatments and follow-ups are done. This means researchers have collected the last data point from the last patient undergoing treatment. At this point, researchers examine the study results.
In the case of a clinical trial on mesothelioma treatment, this analysis helps answer many questions, including:
- Was the treatment effective?
- Did the benefits of the treatment outweigh the risks?
- Does the treatment require further study?
- Should the treatment be approved by the U.S. Food and Drug Administration (FDA)?
Once study coordinators have finished analyzing results, they may publish them in a medical journal. They may also share the study results in the trial’s ClinicalTrials.gov record.
For more information on clinical trials phases, processes, costs and enrollment, you can visit our Clinical Trials Overview page.
Mesothelioma Advances From Clinical Trials
Some completed clinical trials have tested treatments that substantially improved the prognosis for mesothelioma. Below are a few examples of noteworthy, completed mesothelioma clinical trials.
Completed Mesothelioma Clinical Trials List
Provided below is a list of completed mesothelioma trials.
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Conditions: Mesothelioma
Last Updated: November 21, 2025
Status: Completed
A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study
Conditions: Mesothelioma
Last Updated: October 31, 2025
Status: Completed
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 4, 2025
Status: Completed
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Conditions: Mesothelioma
Last Updated: August 12, 2025
Status: Completed
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Conditions: Mesothelioma
Last Updated: August 1, 2025
Status: Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: July 16, 2025
Status: Completed
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: July 10, 2025
Status: Completed
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: July 10, 2025
Status: Completed
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
Conditions: Mesothelioma
Last Updated: July 8, 2025
Status: Completed
CART-meso in Mesothelin Expressing Cancers
Conditions: Mesothelioma
Last Updated: June 25, 2025
Status: Completed
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: June 18, 2025
Status: Completed
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Conditions: Mesothelioma
Last Updated: June 11, 2025
Status: Completed
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
Conditions: Mesothelioma
Last Updated: May 19, 2025
Status: Completed
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Conditions: Mesothelioma
Last Updated: May 8, 2025
Status: Completed
CAR T Cells in Mesothelin Expressing Cancers
Conditions: Mesothelioma
Last Updated: April 25, 2025
Status: Completed
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
Conditions: Mesothelioma
Last Updated: February 18, 2025
Status: Completed
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Conditions: Mesothelioma
Last Updated: January 15, 2025
Status: Completed
The Registry of Oncology Outcomes Associated with Testing and Treatment
Conditions: Mesothelioma
Last Updated: December 13, 2024
Status: Completed
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Conditions: Mesothelioma
Last Updated: December 4, 2024
Status: Completed
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Conditions: Mesothelioma
Last Updated: October 24, 2024
Status: Completed
HIPEC for Peritoneal Carcinomatosis
Conditions: Mesothelioma
Last Updated: October 22, 2024
Status: Completed
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Conditions: Mesothelioma
Last Updated: October 1, 2024
Status: Completed
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: July 29, 2024
Status: Completed
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions: Mesothelioma
Last Updated: June 27, 2024
Status: Completed
Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
Conditions: Mesothelioma
Last Updated: April 24, 2024
Status: Completed
A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
Conditions: Mesothelioma
Last Updated: December 19, 2023
Status: Completed
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: December 12, 2023
Status: Completed
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Conditions: Mesothelioma
Last Updated: October 9, 2023
Status: Completed
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 28, 2023
Status: Completed
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Conditions: Mesothelioma
Last Updated: September 13, 2023
Status: Completed
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Conditions: Mesothelioma
Last Updated: September 9, 2023
Status: Completed
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Conditions: Mesothelioma
Last Updated: August 23, 2023
Status: Completed
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors
Conditions: Mesothelioma
Last Updated: July 13, 2023
Status: Completed
Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma
Last Updated: June 29, 2023
Status: Completed
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: June 14, 2023
Status: Completed
First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin
Conditions: Mesothelioma
Last Updated: March 17, 2023
Status: Completed
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
Conditions: Mesothelioma
Last Updated: February 7, 2023
Status: Completed
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: November 29, 2022
Status: Completed
Dasatinib in Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: October 27, 2022
Status: Completed
Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 23, 2022
Status: Completed
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 16, 2022
Status: Completed
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Conditions: Mesothelioma
Last Updated: September 9, 2022
Status: Completed
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: August 24, 2022
Status: Completed
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: July 28, 2022
Status: Completed
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Conditions: Mesothelioma
Last Updated: July 18, 2022
Status: Completed
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Conditions: Mesothelioma
Last Updated: June 10, 2022
Status: Completed
Phase I Trial HIPEC With Nal-irinotecan
Conditions: Mesothelioma
Last Updated: May 5, 2022
Status: Completed
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Mesothelioma
Last Updated: April 21, 2022
Status: Completed
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: April 13, 2022
Status: Completed
A Study of LY3023414 in Participants With Advanced Cancer
Conditions: Mesothelioma
Last Updated: April 7, 2022
Status: Completed
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Conditions: Mesothelioma
Last Updated: January 17, 2022
Status: Completed
Intravenous Magnesium in Patients Receiving Cisplatin
Conditions: Mesothelioma
Last Updated: January 10, 2022
Status: Completed
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Conditions: Mesothelioma
Last Updated: November 12, 2021
Status: Completed
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Conditions: Mesothelioma
Last Updated: November 10, 2021
Status: Completed
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Conditions: Mesothelioma
Last Updated: August 16, 2021
Status: Completed
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
Conditions: Mesothelioma
Last Updated: June 30, 2021
Status: Completed
Olaparib in People With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 16, 2021
Status: Completed
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: March 16, 2021
Status: Completed
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 8, 2021
Status: Completed
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: December 16, 2020
Status: Completed
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Conditions: Mesothelioma
Last Updated: October 28, 2020
Status: Completed
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Conditions: Mesothelioma
Last Updated: October 28, 2020
Status: Completed
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 30, 2020
Status: Completed
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 28, 2020
Status: Completed
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Conditions: Mesothelioma
Last Updated: July 30, 2020
Status: Completed
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Mesothelioma
Last Updated: July 6, 2020
Status: Completed
Clinical and Histopathologic Characteristics of BAP1 Mutations
Conditions: Mesothelioma
Last Updated: June 30, 2020
Status: Completed
A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas
Conditions: Mesothelioma
Last Updated: June 24, 2020
Status: Completed
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Conditions: Mesothelioma
Last Updated: May 22, 2020
Status: Completed
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Conditions: Mesothelioma
Last Updated: May 12, 2020
Status: Completed
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 31, 2020
Status: Completed
Gene Therapy for Pleural Malignancies
Conditions: Mesothelioma
Last Updated: March 16, 2020
Status: Completed
Combination Gene Transfer and Chemotherapy
Conditions: Mesothelioma
Last Updated: March 13, 2020
Status: Completed
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Conditions: Mesothelioma
Last Updated: February 27, 2020
Status: Completed
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma
Last Updated: February 19, 2020
Status: Completed
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Conditions: Mesothelioma
Last Updated: November 6, 2019
Status: Completed
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Conditions: Mesothelioma
Last Updated: October 15, 2019
Status: Completed
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Conditions: Mesothelioma
Last Updated: September 27, 2019
Status: Completed
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
Conditions: Mesothelioma
Last Updated: September 19, 2019
Status: Completed
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Conditions: Mesothelioma
Last Updated: August 28, 2019
Status: Completed
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
Conditions: Mesothelioma
Last Updated: July 16, 2019
Status: Completed
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Conditions: Mesothelioma
Last Updated: June 5, 2019
Status: Completed
18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: Mesothelioma
Last Updated: December 11, 2018
Status: Completed
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: September 17, 2018
Status: Completed
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Conditions: Mesothelioma
Last Updated: July 2, 2018
Status: Completed
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Conditions: Mesothelioma
Last Updated: May 4, 2018
Status: Completed
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Mesothelioma
Last Updated: March 13, 2018
Status: Completed
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma
Last Updated: December 27, 2017
Status: Completed
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: November 27, 2017
Status: Completed
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Conditions: Mesothelioma
Last Updated: November 3, 2017
Status: Completed
Autologous Redirected RNA Meso-CIR T Cells
Conditions: Mesothelioma
Last Updated: September 16, 2017
Status: Completed
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
Conditions: Mesothelioma
Last Updated: July 17, 2017
Status: Completed
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Conditions: Mesothelioma
Last Updated: April 24, 2017
Status: Completed
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 19, 2017
Status: Completed
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: December 5, 2016
Status: Completed
Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Mesothelioma
Last Updated: October 26, 2016
Status: Completed
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Conditions: Mesothelioma
Last Updated: September 28, 2016
Status: Completed
Capecitabine in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: July 12, 2016
Status: Completed
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: July 11, 2016
Status: Completed
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: June 30, 2016
Status: Completed
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Conditions: Mesothelioma
Last Updated: February 2, 2016
Status: Completed
B-Receptor Signaling in Cardiomyopathy
Conditions: Mesothelioma
Last Updated: November 16, 2015
Status: Completed
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: November 16, 2015
Status: Completed
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Conditions: Mesothelioma
Last Updated: October 19, 2015
Status: Completed
Intrapleural Gene Transfer for Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: September 21, 2015
Status: Completed
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Mesothelioma
Last Updated: July 7, 2015
Status: Completed
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: July 7, 2015
Status: Completed
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Conditions: Mesothelioma
Last Updated: April 29, 2015
Status: Completed
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: April 29, 2015
Status: Completed
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
Conditions: Mesothelioma
Last Updated: April 28, 2015
Status: Completed
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Conditions: Mesothelioma
Last Updated: April 21, 2015
Status: Completed
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 28, 2015
Status: Completed
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Mesothelioma
Last Updated: July 25, 2014
Status: Completed
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Conditions: Mesothelioma
Last Updated: July 23, 2014
Status: Completed
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
Conditions: Mesothelioma
Last Updated: July 16, 2014
Status: Completed
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate
Conditions: Mesothelioma
Last Updated: March 26, 2014
Status: Completed
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 26, 2014
Status: Completed
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
Conditions: Mesothelioma
Last Updated: March 4, 2014
Status: Completed
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: February 10, 2014
Status: Completed
Rapamycin With Grapefruit Juice for Advanced Malignancies
Conditions: Mesothelioma
Last Updated: January 16, 2014
Status: Completed
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Conditions: Mesothelioma
Last Updated: January 14, 2014
Status: Completed
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Conditions: Mesothelioma
Last Updated: July 9, 2013
Status: Completed
Alanosine in Treating Patients With Cancer
Conditions: Mesothelioma
Last Updated: June 25, 2013
Status: Completed
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
Conditions: Mesothelioma
Last Updated: June 17, 2013
Status: Completed
Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
Conditions: Mesothelioma
Last Updated: June 4, 2013
Status: Completed
SU5416 in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: May 31, 2013
Status: Completed
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 16, 2013
Status: Completed
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
Conditions: Mesothelioma
Last Updated: January 23, 2013
Status: Completed
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Conditions: Mesothelioma
Last Updated: January 15, 2013
Status: Completed
Gefitinib in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: January 15, 2013
Status: Completed
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Conditions: Mesothelioma
Last Updated: October 5, 2012
Status: Completed
Interleukin-12 in Treating Patients With Cancer in the Abdomen
Conditions: Mesothelioma
Last Updated: July 27, 2012
Status: Completed
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Conditions: Mesothelioma
Last Updated: March 14, 2012
Status: Completed
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Mesothelioma
Last Updated: March 14, 2012
Status: Completed
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Conditions: Mesothelioma
Last Updated: December 23, 2011
Status: Completed
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
Conditions: Mesothelioma
Last Updated: September 26, 2011
Status: Completed
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
Conditions: Mesothelioma
Last Updated: April 23, 2011
Status: Completed
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: April 7, 2011
Status: Completed
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: March 25, 2011
Status: Completed
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Conditions: Mesothelioma
Last Updated: March 3, 2011
Status: Completed
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: February 25, 2011
Status: Completed
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
Conditions: Mesothelioma
Last Updated: August 2, 2010
Status: Completed
Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: May 1, 2009
Status: Completed
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: January 24, 2007
Status: Completed
